(1)Impact of the CYP3A4*1G polymorphism and its combination with CYP3A5 genotypes on tacrolimuspharmacokinetics in renal transplant patients. 4 M7 w8 {$ ^3 h5 c2 R(2)The effect of CYP3A4*1G allele on the pharmacokinetics of atorvastatin in Chinese Han patients with coronary heart disease.% g% `9 M* {$ C& g, ?' D& N
(3)CYP3A4*1G genetic polymorphism influences CYP3A activity and response to fentanyl in Chinese gynecologic patients